Literature DB >> 32420383

Prevalence of Hyperhomocysteinaemia and Associated Factors among Ethiopian Adult Population in a 2015 National Survey.

Feyissa Challa1, Tigist Getahun1, Meron Sileshi1, Bikila Nigassie1, Zeleke Geto1, Genet Ashibire1, Terefe Gelibo2, Solomon Teferra3, Daniel Seifu4, Yohannes Sitotaw5, Abebe Bekele6, Ebba Abate1, Kaleab Baye7.   

Abstract

Hyperhomocysteinaemia (HHcy) is an independent risk factor for major cardiovascular diseases, but data on the prevalence and predictors of HHcy in low- and middle-income countries like Ethiopia are scant. The aim of this study was to estimate the prevalence of HHcy and associated risk factors in the Ethiopian adult population. A cross-sectional survey on risks of noncommunicable diseases (NCDs) using the STEPwise approach to surveillance (STEPS) survey was conducted between April and June 2015. A total of 4,175 study participants were surveyed. Serum homocysteine (Hcy) and metabolic profile were determined using Cobas Integra 400 Plus and CardioChek PA analyzer, respectively. Factors associated with HHcy were determined using logistic regression. The mean serum tHcy concentration was 14.6 μmol/L, with 16.4 μmol/L in males and 13.4 μmol/L in females. Overall, 38% had HHcy, with figures in males (49%) higher than females (30%). Increased age, being male, and high blood pressure and/or taking blood pressure medication, as well as low consumption of fruit and/or vegetables, were independent risk factors for HHcy. In conclusion, the prevalence of HHcy among the adult Ethiopian population is alarmingly high. Improving diets through the promotion of fruit and vegetable consumption is needed to reduce the risk of NCDs.
Copyright © 2020 Feyissa Challa et al.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32420383      PMCID: PMC7201487          DOI: 10.1155/2020/9210261

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


1. Introduction

Homocysteine (Hcy), 2-methyl-4-mercapto butyric acid, is a sulfur-containing amino acid required for normal biosynthesis of the amino acids methionine and cysteine [1]. Under normal conditions, serum Hcy concentration is strictly maintained by a complex pathway (remethylation or transsulfuration) which involves different factors such as folic acid, vitamin B12 (cobalamin), vitamin B6 (pyridoxine), methylenetetrahydrofolate reductase enzyme (MTHFR), methionine synthase, and cystathionine beta-synthase [2, 3]. However, folate and B-vitamin deficiencies [4], lifestyle behaviors (e.g., smoking, physical inactivity, and chronic alcohol consumption) [5], and genetic defects (i.e., polymorphisms in MTHFR) [6] are all associated with hyperhomocysteinaemia (HHcy) (Hcy ≥ 15 μmol/L) [7]. HHcy is an independent risk factor for many chronic diseases including cardiovascular-related diseases such as [8] atherosclerosis [9], hypertension [10], stroke and coronary artery diseases [11, 12], and type 2 diabetes [13]. HHcy is also associated with increased risk of neural tube defects [14] and adverse pregnancy outcomes [15]. Every 5 μmol/L increase in Hcy was found to be associated with increased risk of cerebrovascular (59%) and coronary heart diseases (32%) [9]. While Ethiopia has made a remarkable progress in reducing the burden of infectious disease, there is mounting evidence that chronic diseases including cardiovascular diseases (CVDs) and diabetes are on the rise [16]. HHcy could be associated with this rise in the burden on NCDs, but little is known about its prevalence and associated factors. This is unfortunate because such data could help prioritize and inform interventions that aim to reduce the burden of chronic diseases in Ethiopia. Therefore, our study aimed at evaluating the prevalence of HHcy and its associated risk factors in a nationally representative of sample of the Ethiopian adult population. To our knowledge, this is the first nationally representative study that evaluated the prevalence of HHcy and its predictors.

2. Methods

2.1. Study Design

A nation-wide cross-sectional survey on risk factors for NCDs was conducted (April-June 2015) using the World Health Organization (WHO) STEPwise approach to surveillance (STEPS version 3.1) [17]. The data were collected using the following three steps: Step 1: interview-based assessment of demographic and behavioural characteristics of the study population, Step 2: physical measurements to determine proportion of the study population with raised blood pressure, overweight, and obesity, and Step 3: biochemical measurements to determine the proportion of the study population with diabetes, raised blood glucose, and abnormal lipid profile. In addition to core and expanded modules, some optional modules (khat use) were included in each of the three steps. A total of 35 experienced and well-trained survey teams, each comprising three survey members (1 supervisor and 2 data collectors), were involved in the data collection.

2.2. Sampling

A total of 4,175 study participants were included in the national NCD survey. Representative samples of all regions of the country, including Addis Ababa and Dire Dawa city administrations, were collected using the sampling frame of the Ethiopian population and housing census [18]. Study participants meeting the following eligibility criteria were included in the study: 15–69 years of age; permanent residents (>6 months residence) of the survey; and providing consent. Individuals in military camps, dormitories, nursing homes, and refugee camps and pregnant women were excluded from the study. Eligible adults aged 15–69 years in each household were selected using the Kish method [19]. Only one eligible participant per household was selected.

2.3. Ethical Approval

Ethical clearance was obtained from the Ethical Review Committees of the Ethiopian Public Health Institute (EPHI) and the National Research and Ethics Review Committee (NERC). Informed consent was obtained from each study participant or from parents/guardians for children less than 18 years of age. The objectives of the study were explained to the participants by the data collectors. The study was conducted according to the principles expressed in the Declaration of Helsinki. Participants with abnormal physical or laboratory findings were counseled and referred to the nearest health facility for further follow-up and medical care.

3. Data Collection

3.1. Demographic and Lifestyle Factors

Demographic and socioeconomic status, tobacco use, alcohol consumption, fruit and vegetable consumption, physical activity, khat use, and history of raised blood pressure or medication for blood pressure, was assessed. Physical activity levels were assessed and categorized as high, moderate, and low. High-level physical activity was defined as vigorous-intensity activity at least three days per week achieving at least 1500 metabolic equivalent time (MET) minutes per week, or seven or more days of any combination of walking and moderate- or vigorous-intensity activities achieving at least 3000 MET minutes per week. Moderate level physical activity was defined as three or more days of vigorous-intensity activity of at least 20 minutes per day; or five or more days of moderate-intensity activity or walking for at least 30 minutes per day; or five or more days of any combination of walking and moderate- or vigorous-intensity activities achieving at least 600 MET minutes per week. A person not meeting any of the abovementioned criteria was considered to have a low physical activity level [20].

3.2. Fruit and Vegetable Consumption

Fruit and vegetable consumption of study participants was captured by asking about the number of days and servings of fruits and vegetables consumed in a typical week. The following serving sizes were considered: for raw green leafy vegetables, 1 serving = one cup; for cooked or chopped vegetables, 1 serving = ½ cup; for fruit (apple, banana, orange, etc.), 1 serving = 1 medium size piece; for chopped, cooked, and canned fruit, 1 serving = ½ cup; and for juice from fruit, 1 serving = ½ cup. Servings were measured by showing pictorial show cards.

3.3. Physical Measurements

Height and weight were measured using an equipment that uses infrared and ultrasonic technologies (Deluxe model number GBS-721). The instrument measures body weight and height and calculates body mass index (BMI; kg/m2). Blood pressure measurements were taken three times (in three minutes interval) from the right arm of a sitting participant using a Boso-Medicus Uno instrument (Boso, Germany). The participants were allowed to rest for 15 minutes before measurements were taken. The maximum deviation of cuff pressure measurement was ±3 mmHg, and the three measurements were averaged.

3.4. Biochemical Measurements

Both capillary and venous blood samples were obtained after an overnight fast (8–10 h). Capillary blood glucose, total cholesterol, and high-density lipoprotein (HDL) analyses were performed in the field using CardioChek PA Analyzer (Polymer Technology System Inc., Indianapolis, IN). For tHcy analysis, 3–5 ml of whole blood was collected and immediately centrifuged at 3500 rpm to separate serum. Serum samples were transported and stored at −80°C at EPHI-Clinical Chemistry Laboratory until further analyses. Serum tHcy and triglycerides were analyzed using Cobas Integra 400® Plus (Roche Diagnostics GmbH, Mannheim, Germany) at the Clinical Chemistry Laboratory of EPHI [21, 22].

3.5. Data Management

Descriptive statistics were calculated for all of the variables. Continuous variables were reported as mean and standard deviation (SD). Categorical variables were reported as frequencies and percentages. Differences in subgroups were analyzed using chi-square. Logistic regression was run to identify risk factors associated with HHcy, after adjusting for covariates gender, age, BMI, residence, marital status, occupational status, level of education, income, physical activity, fruit and/or vegetable consumption, blood glucose, total cholesterol, triglycerides, smoking status, alcohol drinking status, and raised blood pressure or taking blood pressure medication. Hcy values were categorized as normal (Hcy value <15 μmol/L) and HHcy (Hcy value ≥ 15 μmol/L). Odds ratio (OR) and corresponding 95% confidence intervals (CIs) are presented. The data were analyzed using the SPSS software version 22.00 (SPSS Inc. Chicago, IL, USA), and mean differences with p values <0.05 were considered statistically significant.

4. Results

About 60% of the study participants were females and 39% were 15–29 years of age (Table 1). About half (53%) of the study participants had no formal education. More than two-thirds of the study participants had a high level of physical activity, about 5% were smokers, and >90% consumed alcohol (Table 2). Only 1% met the WHO criteria for adequate fruit and vegetable consumption. About a third of the participants were either undernourished (24%; BMI < 18.5) or overweight/obese (8%; BMI > 25.0). Among study participants, 3% had raised blood sugar, and 17% had high blood pressure or were on blood pressure medication, 24% had high serum triglyceride level, and greater than 60% of the participants had a low HDL level.
Table 1

Sociodemographic characteristics of the study participants, Ethiopia, 2015.

Variables n (%)TotalMaleFemale
4175 (100)1722 (41.2)2453 (58.8)
Age (years)
 15–291625 (38.9)626 (36.4)999 (40.7)
 30–441526 (36.6)621 (36.1)905 (36.9)
 45–59739 (17.7)337 (19.6)402 (16.4)
 60–69285 (6.8)138 (8.0)147 (6.0)

Residence
 Urban952 (22.8)283 (16.4)669 (27.3)
 Rural3223 (77.2)1439 (83.6)1784 (72.7)

BMI (kg/m2)
 Low (≤18.5)956 (23.9)452 (26.4)504 (22.0)
 Normal (19–24)2703 (67.5)1161 (67.9)1542 (67.2)
 High (≥25)348 (8.7)98 (5.7)250 (10.9)

Geographic region
 Tigray682 (16.3)257 (14.9)425 (17.3)
 Afar167 (4.0)63 (3.7)104 (167)
 Amhara794 (19.0)343 (19.9)451 (18.4)
 Oromiya961 (23.0)392 (22.8)569 (23.2)
 Somali276 (6.6)105 (6.1)171 (7.0)
 B. Gumuz214 (5.1)104 (6.0)110 (4.5)
 SNNPR527 (12.6)232 (13.5)295 (12.0)
 Gambela239 (5.7)131 (7.6)108 (4.4)
 Harari59 (1.4)22 (1.3)37 (1.5)
 Dire Dawa51 (1.2)30 (1.7)21 (0.9)
 Addis Ababa205 (4.9)43 (2.5)162 (6.6)

Marital status
 Single1326 (31.8)466 (27.1)860 (35.1)
 Married or cohabiting2848 (68.2)1256 (72.9)1592 (64.9)

Occupational status
 Employed379 (9.2)216 (12.8)163 (6.7)
 Skilled worker2336 (56.7)1248 (74.2)1088 (44.6)
 Housewife959 (23.3)8 (0.5)951 (39.0)
 Unemployed446 (10.8)211 (12.5)235 (446)

Level of education
 No formal education2227 (53.3)712 (41.3)1515 (61.8)
 Primary education1472 (35.3)762 (44.3)710 (28.9)
 Secondary education259 (6.2)113 (6.6)146 (6.0)
 College and above217 (5.2)135 (7.8)82 (3.3)

Income (x 1000 birr)
 <122335 (68.1)922 (63.3)1413 (71.6)
 12–18422 (12.3)200 (13.7)222 (11.2)
 18–23206 (6.0)115 (7.9)91 (4.6)
 23–30213 (6.2)96 (6.6)117 (5.9)
 >30254 (7.4)123 (8.4)131 (6.6)

BMI, = body mass index; low BMI ≤ 18.5 kg/m2; normal BMI = 18.5–24.99 kg/m2; high BMI ≥ 25 kg/m2.

Table 2

Lifestyle factors and biochemical measures of study participants, Ethiopia, 2015.

Variables n (%)TotalMaleFemale p value
4175 (100)1722 (41.2)2453 (58.8)
Physical activity level
 Low609 (14.7)159 (9.3)450 (18.5) <0.001
 Moderate679 (16.4)178 (10.4)501 (20.6)
 High2850 (68.9)1372 (80.3)1478 (60.8)

Current smoking
 Yes233 (5.6)202 (11.7)31 (1.3) <0.001
 No3942 (94.4)1520 (88.3)2422 (98.7)

Current alcohol intake
 Yes1708 (92.8)833 (95.3)875 (90.6) <0.001
 No132 (7.2)41 (4.7)91 (9.4)

Fruit and vegetable consumption
 Yes50 (1.2)18 (1.0)32 (1.3)0.448
 No4125 (98.8)1704 (99.0)2421 (98.7)

Blood sugar level
 Normal (<110 mg/dl)3740 (92.5)1546 (92.4)2194 (92.5)0.140
 Impaired fasting glucose (110–125 mg/dl)185 (4.6)69 (4.1)116 (4.9)
 Raised blood sugar (≥126 mg/dl)119 (2.9)58 (3.5)61 (2.6)

Raised blood pressure/on blood pressure medicationΔ
 Yes722 (17.3)280 (16.3)442 (18.0)0.139
 No3453 (82.7)1442 (83.7)2011 (82.0)

Total cholesterol level (mg/dl)
 <2003796 (92.6)1621 (95.3)2175 (90.7) <0.001
 ≥200304 (7.4)80 (4.7)224 (9.3)

Triglyceride level (mg/dl)
 <1503192 (76.5)1319 (76.6)1873 (76.4)0.856
 ≥150983 (23.5)403 (23.4)580 (23.6)

HDL level Φ
 Normal1400 (34.7)673 (40.5)1400 (30.7) <0.001
 Low2630 (65.3)990 (59.5)2630 (69.3)

Homocysteine (μmol/L)b14.6 ± 6.816.4 ± 7.513.4 ± 6.0 <0.001

Homocysteine level (μmol/L)
 <152593 (62.1)879 (51.0)1714 (69.9) <0.001
 ≥151582 (37.9)843 (49.0)739 (30.1)

ΔSBP = systolic blood pressure; DBP = diastolic blood pressure; raised blood pressure (SBP ≥ 140 and/or DBP ≥ 90 mmHg). HDL level: low HDL level for males, <40 mg/dl, and for females, <50 mg/dl. bValues are mean ± standard deviation.

The mean serum tHcy concentration was 14.6 μmol/L, with 16.4 μmol/L in males and 13.4 μmol/L in females. Overall 38% had HHcy, 49% in males and 30% in females (p > 0.05). The prevalence of HHcy increased with age, in both men and women (Table 2). 15–29 years of age had the lowest prevalence of HHcy and 60–69 years of age had the highest prevalence of HHcy (Figure 1).
Figure 1

Mean serum level of homocysteine by age, gender, and residence, Ethiopia, 2015.

The results of the logistic regression analyses for HHcy are presented in Table 3. All factors with a p value <0.05 in the bivariate analysis were entered into the multivariable model that controlled for confounding factors. In bivariate analysis, we did not find any association between HHcy and BMI (p=0.508), marital status (p=0.203), total cholesterol level (p=0.234), triglyceride level (p=0.065), and current alcohol intake (p=0.093). Logistic regression analysis for HHcy using age group, gender, regions, occupational status, level of education, quartiles of income, fruit and/or vegetable consumption, blood glucose level, HDL, smoking status, and raised blood pressure or taking medication as covariates was performed.
Table 3

Factors associated with hyperhomocysteinaemia in the Ethiopian adult population, 2015.

Variables n (%)Homocysteine concentration (Hcy)Adjusted OR (95% CI) p value
<15 μmol/L≥15 μmol/L
Sex
 Female1714 (69.9)739 (30.1)1 <0.001
 Male879 (51.0)843 (49.0)2.16 (1.79, 2.62)

Age (years)
 15–291107 (68.1)518 (31.9)1
 30–44934 (61.2)592 (38.8)1.31 (1.08, 1.58) 0.007
 45–59412 (55.8)327 (44.2)1.80 (1.41, 2.30) <0.001
 60–69140 (49.1)145 (50.9)2.06 (1.47, 2.90) <0.001

Geographic region
 Addis Ababa109 (53.2)96 (46.8)1
 Tigray467 (68.5)215 (31.5)0.50 (0.33, 0.76) 0.001
 Afar85 (50.9)82 (49.1)1.23 (0.74, 2.03)0.433
 Amhara595 (74.9)199 (25.1)0.34 (0.22, 0.51) <0.001
 Oromia639 (66.5)322 (33.5)0.53 (0.36, 0.79) 0.002
 Somali84 (30.4)192 (69.6)3.19 (1.90, 5.34) <0.001
 B. Gumuz103 (48.1)111 (51.9)1.02 (0.62, 1.67)0.954
 SNNPR359 (68.1)168 (31.9)0.49 (0.32, 0.74) 0.001
 Gambela105 (43.9)134 (56.1)1.47 (0.82, 2.62)0.194
 Harari33 (55.9)26 (44.1)1.31 (0.56, 3.07)0.536
 Dire Dawa14 (275)37 (72.5)3.37 (1.46, 7.78) 0.005

Occupational status
 Unemployed281 (63.0)165 (37.0)1
 Employed209 (55.1)170 (44.9)1.17 (0.76, 1.82)0.470
 Skilled worker1437 (61.5)899 (38.5)1.11 (0.77, 1.59)0.583
 Housewife/homemaker646 (67.4)313 (32.6)1.04 (0.69, 1.55)0.863

Level of education
 No formal education1365 (52.6)862 (54.5)1
 Primary education960 (37.0)512 (32.4)0.96 (0.79, 1.17)0.697
 Secondary education157 (6.1)102 (6.4)1.18 (0.82, 1.70)0.379
 College and above111 (4.3)106 (6.7)1.52 (0.98, 2.37)0.063

Income quartiles (×1000 birr)
 <121491 (69.6)844 (65.6)1
 12–18257 (12.0)165 (12.8)1.17 (0.85, 1.62)0.337
 18–23.3110 (5.1)96 (7.5)1.09 (0.75, 1.59)0.643
 23.3–30128 (6.0)85 (6.6)1.22 (0.79, 1.89)0.380
 >30157 (7.3)97 (7.5)1.16 (0.76, 1.78)0.493

Physical activity level
 Low385 (15.0)224 (14.3)1
 Moderate454 (17.6)225 (14.4)1.02 (0.77, 1.36)0.889
 High1734 (67.4)1116 (71.3)1.30 (1.02, 1.66)0.034

Fruit and vegetable consumption
 Yes46 (1.8)4 (0.3)1
 No2547 (98.2)1578 (99.7)9.57 (2.83, 32.30) <0.001

Blood sugar level (mg/dl)
 Normal (<110)2364 (63.2)1376 (36.8)1
 Impaired fasting glucose (110–125)95 (51.4)90 (48.6)1.26 (0.73, 2.16)0.413
 Raised blood sugar (≥126)71 (59.7)48 (40.3)1.44 (0.76, 2.74)0.266

High-density lipoprotein level (HDL)Φ
 Normal824 (58.9)576 (41.1)1
 Low1691 (64.3)939 (35.7)1.09 (0.93, 1.29)0.291

Currently smoking
 No2487 (63.1)1455 (36.9)1
 Yes106 (45.5)127 (54.5)0.84 (0.58, 1.20)0.336

Raised blood pressure/on blood pressure medication Δ
 No2193 (63.5)1260 (36.5)1
 Yes400 (55.4)322 (44.6)1.55 (1.27, 1.91) <0.001

HDL level: low HDL level for males, <40 mg/dl, and for females, <50 mg/dl. ΔSBP = systolic blood pressure; DBP = diastolic blood pressure; raised blood pressure (SBP ≥ 140 and/or DBP ≥ 90 mmHg).

Being male (AOR = 2.16; 95% CI, 1.79–2.62), increased age (AOR = 3.19; 95% CI, 1.90, 5.34), residing in Somali or Dire Dawa region (AOR = 3.37; 95% CI, 1.46–7.78), raised blood pressure (AOR = 1.55; 1.27–1.91), and low fruit and vegetable consumption relative to WHO recommendations (AOR = 9.57; 2.83, 32.30) were independent predictors of increased HHcy.

5. Discussion

The present study has identified that the prevalence of HHcy is alarmingly high. Age, male gender, low fruit and vegetable consumption, and high blood pressure or taking blood pressure medication were the major risk factors. There was also high regional variability in the prevalence of HHcy, with an increased risk of HHcy in some regions (e.g., Dire Dawa and Somali). The high prevalence of HHcy in the Ethiopian population is concerning and could in part explain the increased mortality and morbidity from NCDs in Ethiopia. Indeed, Misganaw et al. [16] have recently shown that ischemic heart disease, ischemic stroke, and diabetes are ranked 1st, 6th, and 8th in the cause of age-standardized death for Ethiopia. While several lifestyle factors such as physical inactivity and smoking are often found to be associated with HHcy [23], these were not significant predictors of HHcy in this Ethiopian sample. This could be due to the high to medium level of physical activity observed in most of our study participants and the relatively low level of smoking. The current study showed that HHcy was higher in males, which is consistent with previous studies [24, 25]. The gender difference in HHcy is likely to be associated with sex-related hormones, the higher phosphocreatine synthesis in males, and the higher rate of remethylation and transmethylation in females than in males [26]. In this study, similar to previous findings [25, 27], the prevalence of HHcy increased with age. This might be due to reduced bioavailability of folate with age [28]. Low consumption of fruits and vegetables and high blood pressure were major predictors of HHcy. Indeed, many studies have documented the advantage of increased fruit and vegetable consumption in promoting health and preventing NCDs including cardiovascular diseases [29]. There could be several explanations for this: First, dark green leafy vegetables are particularly good sources of folate, and adequate folate status could decrease the risk of HHcy. The low level of fruit and vegetable consumption is in line with the findings of the National Food Consumption Survey and is further supported by the relatively high prevalence of folate deficiency in Ethiopia [30, 31]. Second, fruits and vegetables are good sources of antioxidants and polyphenols that can help lower total serum Hcy, prevent lipid oxidation in arterial vessel walls, lower blood pressure, and improve endothelial function. This is supported by a recent study that used a quantile regression approach to show the inverse relationship between fruit and vegetable consumption and serum Hcy [32]. The high regional variability in the prevalence of HHcy could thus partly be attributed to variability in regional dietary patterns, but this would warrant further studies. For instance, Somali and Dire Dawa had the highest HHcy prevalence. These regions also have one of the lowest consumption of fruits and vegetables [30, 33]. Different studies indicated that Hcy is considered as a risk factor for hypertension even though the causal relationship between hypertension and Hcy is limited. HHcy is often accompanied by increased reactive oxygen species, matrix metalloproteinase, and decreased endothelial nitric oxide which all causes stiffness and vascular constriction that can lead to hypertension [34]. In this study, raised blood pressure or taking blood pressure medication was associated with HHcy. The present study had several strengths, including the nationally representative sampling, large sample size, investigation of lifestyle factors, anthropometry, and several biomarkers associated with HHcy. However, certain limitations need to be considered when interpreting our findings. First, the present study is cross-sectional, and hence, causal inferences cannot be made. Second, even though MTHFR 677CT polymorphism and intake of folate and vitamin B12 can all affect serum tHcy concentrations, they were not assessed in the present study; however, fruit and vegetable consumption was assessed to reflect dietary patterns.

6. Conclusions

Despite the abovementioned limitations, the present study is the first nationally representative study that determined the prevalence of HHcy and its associated factors. The study highlighted the alarmingly high prevalence of HHcy, but also showed that increased age, being male, increased blood pressure or taking blood pressure medication, and low fruit and vegetable consumption were key predictors of HHcy. Improving diets through the promotion of fruits and vegetable consumption could be an effective strategy to prevent the adverse effects (i.e., CVD) associated with HHcy.
  25 in total

Review 1.  Homocysteine imbalance: a pathological metabolic marker.

Authors:  Kevin L Schalinske; Anne L Smazal
Journal:  Adv Nutr       Date:  2012-11-01       Impact factor: 8.701

2.  The levels of vitamın B12, folate and homocysteine in mothers and their babies with neural tube defects.

Authors:  Erdal Peker; Nihat Demir; Oğuz Tuncer; Lokman Üstyol; Ragıp Balahoroğlu; Sultan Kaba; Kamuran Karaman
Journal:  J Matern Fetal Neonatal Med       Date:  2015-11-23

3.  Sex-related differences in methionine metabolism and plasma homocysteine concentrations.

Authors:  N K Fukagawa; J M Martin; A Wurthmann; A H Prue; D Ebenstein; B O'Rourke
Journal:  Am J Clin Nutr       Date:  2000-07       Impact factor: 7.045

4.  Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells.

Authors:  M Currò; A Gugliandolo; C Gangemi; R Risitano; R Ientile; D Caccamo
Journal:  Neurochem Res       Date:  2014-05-28       Impact factor: 3.996

5.  B vitamin status, dietary intake and length of stay in a sample of elderly rehabilitation patients.

Authors:  F O'Leary; V M Flood; P Petocz; M Allman-Farinelli; S Samman
Journal:  J Nutr Health Aging       Date:  2011-06       Impact factor: 4.075

6.  Demographic, health, lifestyle, and blood vitamin determinants of serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Vijay Ganji; Mohammmad R Kafai
Journal:  Am J Clin Nutr       Date:  2003-04       Impact factor: 7.045

7.  Clustering of lifestyle risk factors in a general adult population.

Authors:  A Jantine Schuit; A Jeanne M van Loon; Marja Tijhuis; Marga Ocké
Journal:  Prev Med       Date:  2002-09       Impact factor: 4.018

8.  Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45-75 years.

Authors:  Yu Wang; Xiaoying Li; Xianhui Qin; Yefeng Cai; Mingli He; Liming Sun; Jianping Li; Yan Zhang; Genfu Tang; Binyan Wang; Ningling Sun; Xin Xu; Lisheng Liu; Xiping Xu; Yong Huo
Journal:  Br J Nutr       Date:  2012-07-31       Impact factor: 3.718

9.  A quantile regression approach can reveal the effect of fruit and vegetable consumption on plasma homocysteine levels.

Authors:  Eliseu Verly; Josiane Steluti; Regina Mara Fisberg; Dirce Maria Lobo Marchioni
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 10.  B Vitamins and the Brain: Mechanisms, Dose and Efficacy--A Review.

Authors:  David O Kennedy
Journal:  Nutrients       Date:  2016-01-27       Impact factor: 5.717

View more
  1 in total

1.  Prevalence and risk factors for hyperhomocysteinemia: a population-based cross-sectional study from Hunan, China.

Authors:  Yide Yang; Yuan Zeng; Shuqian Yuan; Ming Xie; Yanhui Dong; Jian Li; Quanyuan He; Xiangli Ye; Yuan Lv; Carl-Friedrich Hocher; Bernhard K Kraemer; Xiuqin Hong; Berthold Hocher
Journal:  BMJ Open       Date:  2021-12-06       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.